BIO.B (Bio-Rad Laboratories) Short-Term Debt : $1 Mil (As of Dec. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Bio-Rad Laboratories Short-Term Debt?

Bio-Rad Laboratories's Short-Term Debt for the quarter that ended in Dec. 2024 was $1 Mil.

Bio-Rad Laboratories's quarterly Short-Term Debt increased from Jun. 2024 ($0 Mil) to Sep. 2024 ($1 Mil) but then declined from Sep. 2024 ($1 Mil) to Dec. 2024 ($1 Mil).

Bio-Rad Laboratories's annual Short-Term Debt increased from Dec. 2022 ($0 Mil) to Dec. 2023 ($1 Mil) and increased from Dec. 2023 ($1 Mil) to Dec. 2024 ($1 Mil).

Bio-Rad Laboratories Short-Term Debt Historical Data

The historical data trend for Bio-Rad Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Short-Term Debt Chart

Bio-Rad Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

1.30

0.49

0.47

0.50

1.20

Bio-Rad Laboratories Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															0.50	-	-	1.26	1.20

Bio-Rad Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Bio-Rad Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (NYSE:BIO.B) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

BIO:USA BUWA:Germany BUWA:Germany

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.